Clinical data | |
---|---|
Trade names | Cloxapen, others |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | By mouth, IM |
ATC code | |
Pharmacokinetic data | |
Bioavailability | 37 to 90% |
Protein binding | 95% |
Elimination half-life | 30 minutes to 1 hour |
Excretion | kidney and biliary |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.468 |
Chemical and physical data | |
Formula | C19H18ClN3O5S |
Molar mass | 435.88 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Cloxacillin is an antibiotic useful for the treatment of several bacterial infections.[1] This includes impetigo, cellulitis, pneumonia, septic arthritis, and otitis externa.[1] It is not effective for methicillin-resistant Staphylococcus aureus (MRSA).[2] It can be used by mouth and by injection.[1]
Side effects include nausea, diarrhea, and allergic reactions including anaphylaxis.[1] Clostridioides difficile diarrhea may also occur.[2] It is not recommended in people who have previously had a penicillin allergy.[1] Use during pregnancy appears to be relatively safe.[1] Cloxacillin is in the penicillin family of medications.[2]
Cloxacillin was patented in 1960 and approved for medical use in 1965.[3] It is on the World Health Organization's List of Essential Medicines.[4] It is not commercially available in the United States.[2]